Uberto Fumagalli Romario

Medicine & Life Sciences

1. Stomach Neoplasms 100%
2. Esophageal Achalasia 73%
3. Esophagectomy 70%
4. Multicenter Studies 67%
5. Gastrectomy 53%
6. Esophagus 51%
7. Esophageal Neoplasms 49%
8. Fundoplication 47%
9. Italy 46%
10. Myotomy 43%
11. Stomach 40%
12. Adenocarcinoma 39%
13. Anastomotic Leak 39%
14. Heller Myotomy 37%
15. Laparoscopy 36%
16. Deglutition Disorders 33%
17. Prospective Studies 32%
18. Neoplasms 30%
19. Indocyanine Green 30%
20. Oxaliplatin 30%
21. Herniorrhaphy 30%
22. Lymph Node Excision 30%
23. Esophagogastric Junction 28%
24. Survival 27%
25. Drug Therapy 27%
26. Diverticulum 26%
27. Capecitabine 26%
28. Coronavirus 26%
29. Inguinal Hernia 25%
30. Retrospective Studies 24%
31. HLA-DQ1 antigen 24%
32. Recurrence 23%
33. Gastroesophageal Reflux 23%
34. Therapeutics 23%
35. Colectomy 22%
36. Length of Stay 22%
37. Morbidity 22%
38. Postoperative Complications 21%
39. Laparoscopic Cholecystectomy 21%
40. Elderly 21%
41. Dilatation 21%
42. Mortality 21%
43. Randomized Controlled Trials 21%
44. Rectal Neoplasms 21%
45. Esophageal Diseases 21%
46. Surgeons 19%
47. Optical Imaging 18%
48. Gastrointestinal Stromal Tumors 18%
49. Fluorouracil 18%
50. Disease Outbreaks 18%